Hallux Valgus (Bunion) Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight | Key Companies – Analgesics, Pacira Pharmaceuticals

DelveInsight’s “Hallux Valgus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hallux Valgus, historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Hallux Valgus market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

To Know in detail about the Hallux Valgus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hallux Valgus Market Insights

Hallux Valgus Overview

Hallux valgus, commonly known as a bunion, is one of the most common progressive forefoot deformities across the globe. A bunion is basically a “bump” which develops at the joint of the big toe—the metatarsophalangeal (MTP) joint. The big toe is made up of two joints. The larger of the two is the MTP, where the first long bone of the foot (metatarsal) meets the first bone of the toe (phalanx).

Some of the key facts of the Hallux Valgus Market Report: 

• The Hallux Valgus market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• As per a study titled “Epidemiology and impact of hallux valgus: more than just bunions”, the estimated prevalence of Hallux Valgus was found to be 23% in adults aged 18 to 65 years
• The National health surveys in the United States have reported a prevalence of 0.9% across all age groups, while another survey in the United Kingdom reported a prevalence of 28.4% in adults
• According to the French company, DJO Global, the pooled prevalence estimates indicate that Hallux Valgus affects 23% of adults aged 18-65 and 35% of people aged over 65 in France
• Key Hallux Valgus Companies: Concentric Analgesics, Pacira Pharmaceuticals, Taiwan Liposome Company, Cali Biosciences, and others
• Key Hallux Valgus Therapies: CA-008 (vocacapsaicin), Bupivacaine liposome Injectable suspension, TLC590 (ropivacaine), CPL-01, and others

Get a Free sample for the Hallux Valgus Market Report – 

https://www.delveinsight.com/sample-request/hallux-valgus-market

Key benefits of the Hallux Valgus Market report:

1. Hallux Valgus market report covers a descriptive overview and comprehensive insight of the Hallux Valgus Epidemiology and Hallux Valgus market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Hallux Valgus market report provides insights on the current and emerging therapies.
3. Hallux Valgus market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Hallux Valgus market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Hallux Valgus market.

Download the report to understand which factors are driving Hallux Valgus epidemiology trends @ Hallux Valgus Epidemiological Insights 

Hallux Valgus Market  

The dynamics of the Hallux Valgus market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

Hallux Valgus Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Hallux Valgus Epidemiology Segmentation:

The Hallux Valgus market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Hallux Valgus
• Prevalent Cases of Hallux Valgus by severity
• Gender-specific Prevalence of Hallux Valgus
• Diagnosed Cases of Episodic and Chronic Hallux Valgus

Hallux Valgus Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hallux Valgus market or expected to get launched during the study period. The analysis covers Hallux Valgus market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hallux Valgus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Hallux Valgus market share @ Hallux Valgus market forecast

Hallux Valgus Therapies and Key Companies

• CA-008 (vocacapsaicin): Concentric Analgesics
• Bupivacaine liposome Injectable suspension: Pacira Pharmaceuticals
• TLC590 (ropivacaine): Taiwan Liposome Company
• CPL-01: Cali Biosciences

Hallux Valgus Market Drivers

• The shift in treatment paradigm from conservative therapies to new generation Minimal Invasive options. At present, 3-D correction system is also available in the market

Scope of the Hallux Valgus Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Hallux Valgus Companies: Concentric Analgesics, Pacira Pharmaceuticals, Taiwan Liposome Company, Cali Biosciences, and others
• Key Hallux Valgus Therapies: CA-008 (vocacapsaicin), Bupivacaine liposome Injectable suspension, TLC590 (ropivacaine), CPL-01, and others
• Hallux Valgus Therapeutic Assessment: Hallux Valgus current marketed and Hallux Valgus emerging therapies
• Hallux Valgus Market Dynamics: Hallux Valgus market drivers and Hallux Valgus market barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Hallux Valgus Unmet Needs, KOL’s views, Analyst’s views, Hallux Valgus Market Access and Reimbursement 

Hallux Valgus Market Barriers

• Entry of new-generation medical devices which are pocket-friendly, with faster healing time, bio-compatible and do not need to be removed again, can be a hit. In addition to this, products which are tackling the issue of recurrence in Bunion patients, can grab a huge market share, as majority of patients went through surgery complain about this

Table of Contents 

1. Hallux Valgus Market Report Introduction

2. Executive Summary for Hallux Valgus

3. SWOT analysis of Hallux Valgus

4. Hallux Valgus Patient Share (%) Overview at a Glance

5. Hallux Valgus Market Overview at a Glance

6. Hallux Valgus Disease Background and Overview

7. Hallux Valgus Epidemiology and Patient Population

8. Country-Specific Patient Population of Hallux Valgus 

9. Hallux Valgus Current Treatment and Medical Practices

10. Hallux Valgus Unmet Needs

11. Hallux Valgus Emerging Therapies

12. Hallux Valgus Market Outlook

13. Country-Wise Hallux Valgus Market Analysis (2019–2032)

14. Hallux Valgus Market Access and Reimbursement of Therapies

15. Hallux Valgus Market Drivers

16. Hallux Valgus Market Barriers

17.  Hallux Valgus Appendix

18. Hallux Valgus Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

To know more about Hallux Valgus treatment, visit @ Hallux Valgus Medications

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services